In Depth 10 Feb 2025 Monoclonal antibodies: are they the key to treating Alzheimer’s disease? A major stride in treating Alzheimer’s disease has been the development of monoclonal antibodies. February 10, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Feb 2025 Top biotech deals of January 2025 January 2025 kicked off in full swing with several biotech deals in the biopharma industry. February 6, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 4 Feb 2025 World Cancer Day: trends in cancer therapeutics to look forward to in 2025 As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer care in 2025. February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 13 Dec 2024Finding new treatments for peanut allergy Individuals with peanut allergies are at constant risk of severe reactions, and this week, we talk about new treatments with Jessica Grossman of IgGenix. December 13, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Reports Produced by Inpart 11 Dec 2024Antibody Therapy R&D trends and breakthrough innovations Check out a new report exploring R&D trends and breakthrough innovations leveraging antibodies to create potentially game-changing therapies, published by our parent company Inpart. December 11, 2024 Share WhatsApp Twitter Linkedin Email Produced by Inpart
Sponsored by Allucent 26 Nov 2024 Harnessing antibody-drug conjugates (ADCs) in oncology: Pathways to clinical success Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of cancer treatment. November 26, 2024 - 8 minutesmins - By Will Chu Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Nov 2024 Six bispecific antibody companies you should know about Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients. November 19, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 18 Sep 2024 Two targets, one solution: The rise of bispecific antibodies Find out all you need to know about bispecific antibodies, including how they work and what the current clinical landscape looks like. September 18, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Sponsored by KBI Biopharma 17 Sep 2024 ADCs that deliver: The secret lies in rigorous characterization Explore the challenges of ADC characterization, key techniques, and the benefits of partnering with a CDMO for effective development. September 17, 2024 - 7 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 3 Sep 2024 The crucial role of GS-CHO innovation in biopharmaceutical progress Learn how GS-CHO systems are advancing to improve yields and quality in biomanufacturing, meeting the rising need for effective therapeutic proteins. September 3, 2024 - 8 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 May 2024 Eight monoclonal antibody biotechs making strides in the clinic In this article, we take a look at eight biotechs advancing their monoclonal antibodies through the clinic that have made the news in recent times. May 2, 2024 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 26 Mar 2024 Large molecule manufacturing: addressing challenges with strategies for success Discover the landscape of large molecule manufacturing, exploring challenges, latest innovations, and winning strategies for success. March 26, 2024 - 8 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email